Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
- - - 4
23
20
24
22
19
12
15
16
15
12
22
14
12
13
Average 16
Weighted average by Cap. 19
Other Biotechnology & Medical Research